BVF INC/IL - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 77 filers reported holding OVID THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$2,964,357
-74.8%
3,853,8180.0%0.08%
-74.3%
Q1 2024$11,754,145
-46.7%
3,853,818
-43.7%
0.32%
-41.5%
Q4 2023$22,060,384
-16.1%
6,851,0510.0%0.55%
-22.1%
Q3 2023$26,308,036
+17.1%
6,851,0510.0%0.71%
+13.3%
Q2 2023$22,471,447
+27.1%
6,851,0510.0%0.63%
-3.1%
Q1 2023$17,675,712
+38.7%
6,851,0510.0%0.65%
+20.1%
Q4 2022$12,742,955
+1.1%
6,851,0510.0%0.54%
+3.3%
Q3 2022$12,606,000
-14.4%
6,851,0510.0%0.52%
-26.7%
Q2 2022$14,730,000
-31.5%
6,851,0510.0%0.71%
-17.4%
Q1 2022$21,512,000
+1.1%
6,851,051
+3.3%
0.86%
+11.4%
Q4 2021$21,286,000
-4.5%
6,631,0510.0%0.77%
-11.0%
Q3 2021$22,280,000
-14.1%
6,631,0510.0%0.87%
-10.6%
Q2 2021$25,927,000
+0.5%
6,631,051
+3.3%
0.97%
+0.5%
Q1 2021$25,799,000
+147.0%
6,417,551
+41.9%
0.97%
+135.3%
Q4 2020$10,446,000
-49.8%
4,522,051
+24.8%
0.41%
-63.7%
Q3 2020$20,791,000
+17.9%
3,622,051
+51.4%
1.13%
+4.1%
Q2 2020$17,630,000
+360.1%
2,392,151
+86.0%
1.09%
+204.5%
Q1 2020$3,832,000
+25.8%
1,286,004
+75.1%
0.36%
+54.5%
Q4 2019$3,047,000
-59.5%
734,301
-68.4%
0.23%
-70.8%
Q3 2019$7,521,000
+13.5%
2,321,236
-35.2%
0.79%
+9.1%
Q2 2019$6,629,000
+13.7%
3,583,236
+8.8%
0.72%
+10.9%
Q1 2019$5,829,0003,293,0000.65%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,540,671$2,835,0001.27%
Madison Avenue Partners, LP 1,394,022$2,565,0000.55%
BVF INC/IL 6,851,051$12,606,0000.52%
CHI Advisors LLC 864,822$1,591,0000.43%
Rubric Capital Management LP 4,516,300$8,310,0000.42%
EcoR1 Capital, LLC 6,117,400$11,256,0000.33%
Artal Group S.A. 2,500,000$4,600,0000.20%
DCF Advisers, LLC 162,701$299,0000.19%
Oasis Management Co Ltd. 270,000$497,0000.08%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 908,500$1,672,0000.04%
View complete list of OVID THERAPEUTICS INC shareholders